| |
| |
|
| Insider
Information: |
Hobden Adrian N |
| Relationship: |
President and CEO, Dir... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
442,443 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,559,550 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
442,443 |
|
|
| Total
Value |
$4,559,550 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myriad Genetics Inc |
MYGN |
Pres. Myriad Pharmaceu... |
2009-06-08 |
234,071 |
2004-08-05 |
0 |
Premium* |
|
|
Myrexis Inc |
MYRX |
President and CEO, Dir... |
2010-09-24 |
208,372 |
2009-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MYRX |
Myrexis Inc |
President and CEO |
• • – |
2010-09-24 |
4 |
A |
$0.00 |
$0 |
D/D |
41,667 |
208,372 |
0 |
- |
|
| MYRX |
Myrexis Inc |
President and CEO |
• • – |
2010-04-16 |
4 |
OE |
$1.38 |
$38,647 |
D/D |
28,005 |
162,787 |
0 |
- |
|
| MYRX |
Myrexis Inc |
President and CEO |
• • – |
2010-03-18 |
4 |
B |
$4.41 |
$88,200 |
D/D |
20,000 |
134,782 |
2.81 |
- |
|
| MYRX |
Myrexis Inc |
President and CEO |
• • – |
2010-03-02 |
4 |
OE |
$1.13 |
$5,493 |
D/D |
4,480 |
114,782 |
0 |
- |
|
| MYRX |
Myrexis Inc |
President and CEO |
• • – |
2009-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
108,517 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2009-06-08 |
4 |
OE |
$10.28 |
$399,950 |
D/D |
37,158 |
234,071 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2009-05-27 |
4 |
OE |
$2.39 |
$95,620 |
D/D |
40,000 |
235,726 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2009-05-27 |
4 |
S |
$34.01 |
$1,360,568 |
D/D |
(40,000) |
195,726 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2009-05-08 |
4 |
OE |
$5.37 |
$99,991 |
D/D |
17,742 |
195,726 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2009-02-05 |
4 |
OE |
$4.78 |
$114,744 |
D/D |
24,000 |
112,992 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2009-02-05 |
4 |
S |
$83.60 |
$2,006,366 |
D/D |
(24,000) |
88,992 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2008-12-11 |
4 |
S |
$60.60 |
$1,212,066 |
D/D |
(20,000) |
88,992 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2008-12-11 |
4 |
OE |
$4.78 |
$95,620 |
D/D |
20,000 |
108,992 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2008-09-29 |
4 |
OE |
$5.13 |
$107,974 |
D/D |
21,068 |
88,992 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2008-09-25 |
4 |
S |
$68.54 |
$1,028,138 |
D/D |
(15,000) |
67,924 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2008-09-23 |
4 |
OE |
$5.13 |
$51,250 |
D/D |
10,000 |
82,924 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2008-09-19 |
4 |
S |
$66.00 |
$65,472 |
D/D |
(992) |
72,924 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2008-09-19 |
4 |
OE |
$5.13 |
$5,084 |
D/D |
992 |
73,916 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2008-09-18 |
4 |
OE |
$5.13 |
$51,250 |
D/D |
10,000 |
72,924 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2008-09-17 |
4 |
S |
$66.49 |
$33,245 |
D/D |
(500) |
62,924 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2008-09-17 |
4 |
OE |
$5.13 |
$2,563 |
D/D |
500 |
63,424 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2008-08-25 |
4 |
S |
$65.03 |
$1,785,951 |
D/D |
(27,464) |
62,924 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2008-08-25 |
4 |
OE |
$5.13 |
$140,753 |
D/D |
27,464 |
90,388 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2008-03-10 |
4 |
OE |
$5.13 |
$51,250 |
D/D |
10,000 |
62,618 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Pres. Myriad Pharmaceuticals |
• – – |
2007-11-30 |
4 |
OE |
$5.13 |
$25,625 |
D/D |
5,000 |
52,236 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
